Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872179 · ClinicalTrials.gov registry record
International Registry of Patients With Alpha Thalassemia
A clinical trial of Alpha-Thalassemia and Alpha Thalassemia Major, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04872179 is a study of Alpha-Thalassemia and Alpha Thalassemia Major that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04872179, a study of Alpha-Thalassemia and Alpha Thalassemia Major, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.
Conditions Studied
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-01 |
| Est. Completion | 2037-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04872179
The ClinicalTrials.gov registry entry for NCT04872179 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alpha-Thalassemia appearing as the primary indexed condition, and to 0 interventions.
NCT04872179 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04872179 about?
NCT04872179 is a clinical study titled "International Registry of Patients With Alpha Thalassemia". This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.
What is the current status of trial NCT04872179?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-01. Estimated completion is 2037-01.
What conditions does trial NCT04872179 study?
This clinical trial studies the following conditions: Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor.
Who is sponsoring clinical trial NCT04872179?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04872179 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alpha-Thalassemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.